Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
OCDX was delisted on the 26th of May, 2022.
95 hedge funds and large institutions have $4.52B invested in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in 2021 Q1 according to their latest regulatory filings, with 95 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1,878% more call options, than puts
Call options by funds: $6.21M | Put options by funds: $314K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carlyle Group
Washington,
District of Columbia
|
+$2.53B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$280M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$134M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$125M |
| 5 |
BlackRock
New York
|
+$116M |
Top Sellers
OCDX Hedge Fund Activity: Q1 2021 in Review
95 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) for Q1 2021, worth a combined $4.52B.
Buyers outnumbered sellers: 95 funds opened new OCDX positions and 0 closed out — a net gain of 95 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Carlyle Group, opening a new position worth an estimated $2.53B.
- 95 institutional investors held Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $4.52B of Ortho Clinical Diagnostics Holdings plc Ordinary Shares stock for Q1 2021.
- 95 funds opened new Ortho Clinical Diagnostics Holdings plc Ordinary Shares positions in Q1 2021 and 0 closed out, a net change of +95 holders.
- The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares buyer in Q1 2021 was Carlyle Group, an estimated $2.53B added.
Based on aggregated 13F filings for Q1 2021.